Griffith University's NCNED study reveals elevated brain neurochemical levels in long COVID and ME/CFS patients compared to healthy individuals.

Symptoms linked to these neurochemical changes include cognitive impairment, unrefreshing sleep, pain, and physical limitations.

The research indicates a substantial connection between long COVID and ME/CFS, hinting at common underlying mechanisms.

Findings are published in the American Journal of Medicine, emphasizing a parallel neurochemical signature in long COVID and ME/CFS.

The NCNED, under the guidance of Professor Sonya Marshall-Gradisnik, is well-equipped for advanced MRI and lab research in these conditions and is tracking their health and economic impacts.